GLENMARK PHARMACEUTICALS LTD.

NSE : GLENMARKBSE : 532296ISIN CODE : INE935A01035Industry : Pharmaceuticals & DrugsHouse : Glenmark

BSE407.4014.9 (+3.8 %)

PREV CLOSE ( ) 392.50

OPEN PRICE ( ) 397.50

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 33932

TODAY'S LOW / HIGH ( )397.05 408.80

52 WK LOW / HIGH ( )386.3 690.6

NSE407.5014.85 (+3.78 %)

PREV CLOSE( ) 392.65

OPEN PRICE ( ) 399.00

BID PRICE (QTY) 407.50 (50)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 555699

TODAY'S LOW / HIGH( ) 397.10 409.00

52 WK LOW / HIGH ( )386.2 690.95

More From Company Profile

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 18-11 1977

Management Info

Glenn Saldanha - Chairman Glenn Saldanha - Managing Director

Registered Office

Address B/2 Mahalaxmi Chambers,22 Bhulabhai Desai Road, ,
Mumbai,
Maharashtra-400026

Phone

Email webmaster@glenmarkpharma.com

Website www.glenmarkpharma.com

Registrars Details

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE, MCX

NEWS

21May Glenmark Pharmaceuticals informs about
Glenmark Pharmaceuticals has informed that the US FDA has issued Form 48..

21May USFDA inspects Glenmark Pharmaceutical
The United States Food & Drug Administration (USFDA) has inspected G..

20May Glenmark Pharmaceuticals informs about
Glenmark Pharmaceuticals has informed that it attached media release tod..

20May Glenmark Pharma’s arm gets USFDA’s fin
Glenmark Pharmaceuticals’ subsidiary -- Glenmark Pharmaceuticals Inc., U..

Financials

in Millions

	QTR Dec 21	ANNUAL 21
Net Profit	5485.19	16494.47
Gross Profit	6366.55	19437.57
Operating Profit	7272.25	22865.78
Net Sales	20330.54	75679.33

EVENT CALENDAR

peer group

Dr. Reddy's Lab (BSE) 4246.30 (8.10%)	M.Cap ( in Cr)70669.41
Divi's Lab (BSE) 4306.60 (2.53%)	M.Cap ( in Cr)114326.70
Pfizer (BSE) 4352.00 (2.06%)	M.Cap ( in Cr)19909.41
Alkem Laboratories (BSE) 3001.30 (2.87%)	M.Cap ( in Cr)35885.04
Torrent Pharma (BSE) 2664.45 (2.82%)	M.Cap ( in Cr)45084.82

	MUTUAL FUNDS/UTI	6.18%
	PROMOTERS	46.65%
	NON-INSTITUTION	18.27%
	FI/BANKS/INSURANCE	0.44%
	GOVERNMENT	0%
	FII	0%

Scheme Name	Hold(%)
PGIM India Arbitrag...	1.49
Nippon India Nifty ...	1.47
Aditya Birla SL Nif...	1.37
Axis Healthcare ETF	1.37
ICICI Pru Healthcare ETF	1.37
Tata India Pharma &...	1.33

About Glenmark Pharmaceuticals Ltd.

Glenmark Pharmaceuticals Ltd. was incorporated in the year 1977. Its today's share price is 407.4. Its current market capitalisation stands at Rs 11495.53 Cr. In the latest quarter, company has reported Gross Sales of Rs. 75679.33 Cr and Total Income of Rs.79641.7 Cr. The company's management includes Harish Kuber, Dipankar Bhattacharjee, DR Mehta, Rajesh V Desai, Blanche Elizabeth Saldanha, Brian W Tempest, Saira Ramasastry, Sridhar Gorthi, Bernard Munos, Cherylann Pinto, VS Mani, Glenn Saldanha, Glenn Saldanha.

It is listed on the BSE with a BSE Code of 532296 , NSE with an NSE Symbol of GLENMARK and ISIN of INE935A01035. It's Registered office is at B/2 Mahalaxmi Chambers,22 Bhulabhai Desai Road, Mumbai-400026, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Arthur Andersen & Associates, Price Waterhouse, Suresh Surana & Associates LLP, VK Bahri & Co, Walker Chandiok & Co LLP, Walker, Chandiok & Co, Walker, Chandiok & Co LLP

About Nirmal Bang About Nirmal Bang Awards & Accolades Careers at Nirmal Bang Contact Nirmal Bang

Product & Services Equity & Derivatives Trading Forex Trading Commodity Trading Institutional Broking Depository Services Loan Against Securities (LAS) Algo Trading

Equity Price Analysis Volume Analysis Index Analysis News Analysis Corporate Action India Market Other Market Share Market Holidays

Derivatives Updates Market Report Overview

IPO IPO Issues Performance News & Analysis

Commodities Market Movers News & Commentary MCX / NCDEX Holidays MCX Data feed product and Charges

Mutual Funds About Nirmal Bang Niveshalaya Why Associate with Nirmal Bang Mutual Fund Login Mutual Fund Register FAQs Mutual Fund Holidays SIP Calculator Mutual Funds Updates Mutual Funds Trends Mutual Fund Reports Annual Return 2018 Annual Return 2017 Mutual Fund Terms & Conditions Mutual Privacy Policy

Nirmal Bang Research Technical Calls Equity Reports Commodity Reports Currency Research Institutional Research

Nirmal Bang Media Knowledge Center Blog Support Center Become A Partner Beyond Market Careers Sitemap

Other Links Disclaimer Privacy Policy Terms Of Use Rules & Regulations Disclosures Grievances SEBI Scores RMS Policy Inspection CSR Committee CSR Policy CSR Activities Investor Charter Linked content_Investor Charter for Depositories and DPs Investor Charter for Depositories and DPs

Investor Complaint Data

Connect with Us

ATTENTION INVESTORS Depository IPO KYC

Inactive account treatment NBSPL Policy of AML NBEPL Policy of AML NBSPL CSR Policy Physical Settlement Policy of Derivative Aadhar Updation Nirmalbang Privacy Policy V1.0 Documents in Vernacular Languages NBSPL Disclosure Document March 2019

Nirmal Bang Securities Pvt. Ltd. : Member NSE – ID 09391, SEBI Registration No. NSE CM Segment INZ000202536, Member NSE – ID 09391, SEBI Registration No. NSE FO Segment INZ000202536, Member NSE – ID 09391, SEBI Registration No. NSE CDS Segment INZ000202536, Member NSE Commodity – ID 09391, SEBI Registration No. NSE COMMODITY Segment Exchange Registered Broker, Member MSEI – ID 1067, SEBI Registration No. MSEI CM Segment INZ000202536, Member MSEI – ID 1067, SEBI Registration No. MSEI FO Segment INZ000202536, Member MSEI – ID 1067, SEBI Registration No. MSEI CDS Segment INZ000202536, Member MCX – ID 56460, SEBI Registration No. MCX COMMODITY Segment INZ000202536, Member NCDEX – ID 1268, SEBI Registration No. NCDEX COMMODITY Segment NZ000202536, Member ICEX – ID 2073, SEBI Registration No. ICEX COMMODITY Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE CM Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE FO Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE CDS Segment Exchange Registered Broker, Member BSE Commodity – ID 0498, SEBI Registration No. BSE COMMODITY Segment Exchange Registered Broker, SEBI Registration No. PMS INP000002981, SEBI Registration No. Research Analyst INP000002981, SEBI Registration No. DP Participants NSDL – CDSL IN-DP-CDSL 37-99,Member Comtrack Participant Id – ID 50274, Member NERL RP Id– ID R1447, Nirmal Bang Equities Private Limited Member BSE – ID 245, SEBI Registration No. BSE CM Segment INZ000186135, Member NSE – ID 13437, SEBI Registration No. BSE CM Segment INZ000186135, Member NSE – ID 13437, SEBI Registration No. NSE FO Segment INZ000186135, Member NSE Currency – ID 13437, SEBI Registration No. NSE CDS Segment INZ000186135, Member MSEI – ID 17780, SEBI Registration No. MSEI CM Segment INZ000186135, Member MSEI – ID 17780, SEBI Registration No. MSEI FO Segment INZ000186135, SEBI Registration No. Research Analyst Segment INH000001436, Nirmal Bang Commodities Private Limited Member MCX – ID 16590, SEBI Registration No. MCX COMMODITY Segment INZ000043630, Member NCDEX – ID 00362, SEBI Registration No. NCDEX COMMODITY Segment INZ000043630, Member ICEX – ID 1165, SEBI Registration No. ICEX COMMODITY Segment INZ000043630, Member NCDEX Spot Exchange – ID 10084,Comtrack Participant CPID -5040, Participant CDSL Commodity Repository Limited - 12013300

For any grievances, please get in touch on 022-62739390 and write a mail to Contact@nirmalbang.com with Subject line as Grievances/Complain. |

Designed , Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.

Type	Charges (POA Clients)	Charges (Non-POA Clients)
Margin Pledge Creation/Initiation	INR 10.00 (Per Transaction)	INR 20.00 (Per Transaction)
Margin Pledge Release	INR 10.00 (Per Transaction)	INR 20.00 (Per Transaction)

Stock Price Quote